Total Funding
68
66
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
122008
Zenobia Therapeutics is a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery.
Robert Meadows: Co-Founder- Vicki Nienaber: Co-Founder, CSO and President
Zenobia Fragments
About the Company
Zenobia Therapeutics was founded in 2008 with a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery. In 2014, Zenobia added a products division, Zenobia Fragments that supplies products and services to support fragment-based lead discovery.
Women Founded
